The Role of Biotechnology in Diagnosis and Prevention of Canine Parvovirus: A Model for Small Animal Diseases.

Canine parvovirus (CPV) is one of the most deadly and contagious viral infections that affects dogs worldwide, especially puppies. It is also used as a model to test biotechnology methods in veterinary medicine. Biotechnology has dramatically enhanced the diagnosis and prevention of CPV infections. Molecular techniques like polymerase chain reaction (PCR), real-time PCR, and multiplex PCR have made it possible to quickly, accurately, and very sensitively find the virus. These methods are better than traditional serological and clinical diagnostic procedures. Advances in recombinant DNA technology have made it easier to make subunit and DNA vaccines that target the VP۲ protein. These vaccines are safer and better at protecting the immune system than traditional live-attenuated vaccinations. These advancements underscore the vital importance of biotechnology in diminishing morbidity and mortality rates associated with CPV and illustrate its extensive applicability in the fight against various infectious illnesses in small animals. This paper examines the latest developments in biotechnological instruments for the diagnosis and prevention of CPV, highlighting their capacity to revolutionize small animal veterinary treatment.

کلیدواژه ها:

Canine parvovirus ، Biotechnology ، Molecular diagnostics ، Recombinant vaccines ، Small animal diseases ، Veterinary